Pfizer

Bespoke Gene Therapy Consortium created to collaborate in development of rare disease gene therapies

patients.”. Five major pharma companies have signed up to be part of the BGTC – Biogen, Janssen, Novartis, Pfizer and Takeda – plus smaller companies like REGENXBIO, Spark Therapeutics, Taysha Gene Therapies and

FDA experts recommend COVID-19 vaccine for 5-11 year-olds

The advisory committee voted overwhelmingly to recommend Pfizer-BioNTech’s Comirnaty for children aged 5-11, although some experts expressed concerns. ... The panel of experts reviewed data from Pfizer-BioNTech and an analysis from the FDA to balance

Merck’s COVID-19 antiviral under review in Europe by EMA

250, 000 courses of Pfizer’s antiviral combination PF-07321332 and ritonavir.

Benefits of COVID-19 vaccine in younger children outweigh risks, says FDA

An FDA analysis says the benefit of Pfizer/BioNTech’s COVID-19 vaccine in children aged 5-11 years outweighs the risk, even where the incidence of SARS-CoV-2 is ... Pfizer/BioNTech’s own analysis agrees with the favourable risk-benefit analysis,

Pfizer-BioNTech booster offers 95.6% efficacy against COVID-19

Results from the world’s first randomised, controlled COVID-19 vaccine booster trial show a third dose of Pfizer-BioNTech’s Comirnaty offers near-total protection from infection. ... These results provide further evidence of the benefits of

[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]